Fibrosis (Cirrhosis) Summary

Networked: 52099 relevant articles (2735 outcomes, 5648 trials/studies) for this Disease

Key Drugs and Agents for Fibrosis

1. Collagen : 130 outcomes 200 studies in 3947 results : IBA
   
2. Bleomycin (Blenoxane) : 67 outcomes 137 studies in 1077 results : FDA 7 Generic
   
3. Interferons : 65 outcomes 108 studies in 697 results : IBA
   
4. Non-alcoholic Fatty Liver Disease : 49 outcomes 128 studies in 1465 results : IBA
   
5. Ribavirin (Virazole) : 47 outcomes 80 studies in 433 results : FDA 16 Generic
   
6. Transforming Growth Factor beta (TGF-beta) : 45 outcomes 116 studies in 1452 results : IBA
   
7. Lamivudine (3TC) : 41 outcomes 38 studies in 209 results : FDA 62
   
8. Biological Markers (Surrogate Marker) : 40 outcomes 139 studies in 922 results : IBA
   
9. Messenger RNA (mRNA) : 33 outcomes 67 studies in 1221 results : IBA
   
10. Transforming Growth Factor beta1 (TGF beta 1) : 32 outcomes 66 studies in 733 results : IBA
    

Diseases Related to Fibrosis

1. Inflammation
2. Fibrosis (Cirrhosis)
3. Hepatocellular Carcinoma (Hepatoma)
4. Infection
5. Liver Cirrhosis (Hepatic Cirrhosis)

Key Therapies for Fibrosis

1. Liver Transplantation : 101 outcomes 123 studies in 1940 results
   
2. Transplantation (Transplant Recipients) : 81 outcomes 98 studies in 1128 results
   
3. Transplants (Transplant) : 51 outcomes 145 studies in 1880 results
   
4. Ligation : 22 outcomes 82 studies in 593 results
   
5. Sclerotherapy : 21 outcomes 37 studies in 166 results